A Randomized Controlled Trial Comparing Surgical Decompression With an Interlaminar Implant in Patients With Intermittent Neurogenic Claudication Caused by Lumbar Stenosis

NCT ID: NCT01727752

Last Updated: 2016-03-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

386 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-10-31

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A Randomized, Blinded Comparison of Surgical Intervention with the Coflex® Interspinous Implant versus Surgical Decompression for Patients with Intermittent Neurogenic Claudication caused by Lumbar Stenosis

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this investigation, it will be investigated whether the effectiveness of surgical intervention with Coflex® is equivalent to surgical decompression after 12 months in people with intermittent claudication. The main advantage of coflex® might be a faster recovery after surgery, but after long term follow-up it is unknown if this treatment effect remains. Therefore in addition, it will be investigated whether surgical intervention with coflex® is more effective than surgical decompression on short-term follow-up (8 weeks to 6 months) and whether surgical intervention with coflex® is more cost-effective after 12 months than surgical decompression.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intermittent Neurogenic Claudication (INC) as a Result of Spinal Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgical decompression

Surgical decompression

Group Type ACTIVE_COMPARATOR

Decompression

Intervention Type PROCEDURE

coflex Interlaminar Technology

Surgical decompression followed by implantation of coflex Interlaminar Technology.

Group Type ACTIVE_COMPARATOR

Decompression

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Decompression

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* signed informed consent
* is 40 to 85 years old at time of surgery
* has INC, as noted by leg/buttock/groin pain with or without back pain. Leg/buttock/groin pain needs to be strongly relieved when flexed such as when sitting in a chair
* has received at least three months of conservative care therapy which may have included, but is not limited to, physical therapy, bracing, systemic and/or injected medications
* has a regular indication for surgical intervention of INC
* has a narrowed lumbar spinal canal, nerve root canal or intervertebral foramen at one or two levels confirmed by MRI
* is physically and mentally willing and able to comply with, or has a caregiver who is willing and able to comply with, the post-operative evaluations.

Exclusion Criteria

* has cauda equina syndrome defined as neural compression causing neurogenic bowel (rectal incontinence) or bladder dysfunction (bladder retention or incontinence)
* has Paget's disease, severe osteoporosis or metastasis to the vertebrae
* has significant scoliosis (Cobb angle \> 25 degrees)
* has a Body Mass Index (BMI) \> 40 kg/m2
* has had any surgery of the lumbar spine
* has degenerative spondylolisthesis \> grade 1 (on a scale 1 to 4) at the affected level
* has significant instability of the lumbar spine
* has severe comorbid conditions that will increase the risk to the patient or interfere with the evaluability of this study
* has a fused segment at the indicated level.
* has a herniated disk on the level of interest
Minimum Eligible Age

40 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Paradigm Spine

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sint Lucas Andreas Ziekenhuis

Amsterdam, , Netherlands

Site Status

Reinier De Graaf Gasthuis

Delft, , Netherlands

Site Status

Groene Hart Ziekenhuis

Gouda, , Netherlands

Site Status

Medical Center Alkmaar

Holland, , Netherlands

Site Status

Diaconessenhuis

Leiden, , Netherlands

Site Status

Leiden University Medical Center

Leiden, , Netherlands

Site Status

Rijnland ziekenhuis,

Leiderdorp, , Netherlands

Site Status

Canisius-Wilhelmina Ziekenhuis

Nijmegen, , Netherlands

Site Status

Vlietland Ziekenhuis

Schiedam, , Netherlands

Site Status

Bronovo Ziekenhuis

The Hague, , Netherlands

Site Status

HAGA ziekenhuis

The Hague, , Netherlands

Site Status

Medical Center Haaglanden

The Hague/Leidschendam, , Netherlands

Site Status

Isala Klinieken

Zwolle, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NTR1307

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Restore CLINICAL TRIAL
NCT01609374 UNKNOWN NA